Glaucoma Pipeline Highlights – 2017 Update
The latest report from Fore Pharma, Glaucoma Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Glaucoma market. It covers emerging therapies for Glaucoma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Glaucoma pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Glaucoma pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides Glaucoma pipeline products by the company.
Short-term Launch Highlights:
Find out which Glaucoma pipeline products will be launched in the US and Ex-US till 2020.
SUMMARY:
- Glaucoma phase 3 clinical trial pipeline products
- Glaucoma phase 2 clinical trial pipeline products
- Glaucoma phase 1 clinical trial pipeline products
- Glaucoma preclinical research pipeline products
- Glaucoma discovery stage pipeline products
- Glaucoma pipeline products short-term launch highlights
- 1. Glaucoma Pipeline by Stages
- 2. Glaucoma Pipeline by Drug Class
- 3. Glaucoma Pipeline by Company
- 4. Glaucoma Phase 3 Clinical Trial Insights
- 5. Glaucoma Phase 2 Clinical Trial Insights
- 6. Glaucoma Phase 1 Clinical Trial Insights
- 7. Glaucoma Preclinical Research Insights
- 8. Glaucoma Discovery Stage Insights
- 9. Appendix
- 10. Research Methodology
- LIST OF TABLES
- Table 1: Glaucoma Phase 3 Clinical Trials, 2017
- Table 2: Glaucoma Phase 2 Clinical Trials, 2017
- Table 3: Glaucoma Phase 1 Clinical Trials, 2017
- Table 4: Glaucoma Preclinical Research, 2017
- Table 5: Glaucoma Discovery Stage, 2017
- LIST OF FIGURES
- Figure 1: Glaucoma Pipeline Molecules by Clinical Trials Stage, 2017
- Figure 2: Glaucoma Pipeline Molecules by Drug Class, 2017
- Figure 3: Glaucoma Pipeline Molecules by Company, 2017
- Figure 4: Glaucoma Phase 3 Clinical Trial Highlights, 2017
- Figure 5: Glaucoma Phase 2 Clinical Trial Highlights, 2017
- Figure 6: Glaucoma Phase 1 Clinical Trial Highlights, 2017
- Figure 7: Glaucoma Preclinical Research Highlights, 2017
- Figure 8: Glaucoma Discovery Stage Highlights, 2017
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBookOther tasks
